Nirupama Pike named director of new cell therapy program
The University of Wisconsin School of Medicine and Public Health, in partnership with the UW Carbone Cancer Center, has chosen its first director of cell manufacturing at the Program for Advanced Cell Therapy (PACT).
New pancreatic cancer study uses optical imaging to craft better treatments
Pancreatic cancer research at the University of Wisconsin Carbone Cancer Center (UWCCC) is getting a big boost, thanks to a $3 million grant from the National Cancer Institute.
UW Carbone Cancer Center researchers win two national prostate cancer awards
UW Carbone Cancer Center researchers won two of the six national Challenge Awards announced this week by the Prostate Cancer Foundation and the Movember Foundation.
Study provides cellular explanation for higher risk of prostate cancer in aging men
The link between aging and prostate cancer development is now better understood, based on a study by University of Wisconsin Carbone Cancer Center researchers.
Carbone study find protein that improves immune response in colon cancer
A better understanding of the function of non-cancerous cells and tissue surrounding colon cancer cells is providing a clearer picture of how the immune system recognizes and accesses the cancer site, according to a new study by University of Wisconsin Carbone Cancer Center (UWCCC) researchers.
Andrew Baschnagel wins UW Carbone award for lung cancer study
The University of Wisconsin Carbone Cancer Center (UWCCC) has awarded Dr. Andrew Baschnagel its 2017 Young Investigator Award. Baschnagel is a radiation oncologist who specializes in treating patients with lung and other thoracic cancers. He joined the Cancer Center in 2014.
Carbone Cancer Center members recognized as Vilas Professors
Three UW Carbone Cancer Center members recently earned Vilas Professorships.
New method of viral maintenance in cancer cells identified in UW study
A new method for how viruses ensure their maintenance in dividing cells has been identified by researchers at the University of Wisconsin McArdle Laboratory for Cancer Research and Carbone Cancer Center.
Study links insurance coverage to higher rates of colorectal cancer screenings
As the nation debates whether and how health insurance should be reformed, researchers at the University of Wisconsin School of Medicine and Public Health determined that people with a certain type of insurance policy were more likely to be screened for colorectal cancer.
Viral infection found to increase therapeutic resistance of glioblastoma cells
A common human virus, cytomegalovirus (CMV), can convert glioblastoma (GBM) brain cancer cells into cancer stem cells with higher therapeutic resistance, according to a new study by University of Wisconsin Carbone Cancer Center researchers.
Study sheds light on function of protein associated with high-risk breast cancers
The function of a protein associated with breast cancer development and metastasis is now better understood, based on a new study by University of Wisconsin Carbone Cancer Center (UWCCC) researchers.
Immunotherapy: Harnessing cellular systems to fight deadly diseases
Four decades ago, researchers at the University of Wisconsin School of Medicine and Public Health had the right idea—to pursue a theory that they could harness patients’ own immune systems to fight and defeat cancer. Their perseverance and hard work are paying off, as they’ve recently made great strides in cellular immunotherapy, along with colleagues in myriad medical fields.